Food Supplement Insights
Technical articles from the Nutraceuticals division: ingredient validation, in vitro models, microbiota.
EFSA opinion on Solein: a fermentation-derived ingredient that holds up on process, specifications and an in vitro modelOn 9 November 2026 EFSA concluded that powdered Xanthobacter sp. SoF1 biomass is safe under the proposed conditions of use. The opinion shows what a novel food dossier for a fermentation-derived ingredient rests on.Read →
S-acetyl glutathione: what the EFSA opinion actually saysEFSA has given its safety opinion on S-acetyl glutathione as a novel food. An opinion is not an authorisation, and the months still to run before […]Read →
Lactoferrin: what changes from one form to anotherLactoferrin is one molecule with many commercial forms, and the forms are not equivalent. That is why two supplements declaring the same ingredient can behave differently, […]Read →
Not every ingredient needs a clinical studyEvery company wants clinical evidence. Not every project is ready for it. The question worth asking before opening a budget for a human study is more […]Read →
“Supports microbiota balance”: how you measure it“Supports microbiota balance” has become a line you read everywhere and that says almost nothing. Balance between what? Measured how? The interesting question is not whether […]Read →